DENVER–(BUSINESS WIRE)–The Denver Health and Hospital Authority Board of Directors has announced that Donna Lynne, DrPH, will serve as the next chief executive officer (CEO) to lead Denver Health. “We are confident that Donna’s extensive operational and leadership experience, her deep connections to our Colorado communities and her passion for our mission as a safety-net … [Read more…]
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Technical Safety Services (TSS), a portfolio company of The Edgewater Funds (Edgewater) and JZ Partners (JZ), on its sale to Levine Leichtman Capital Partners (LLCP). TSS is a leading provider of testing, inspection, certification, and calibration (TICC) services to … [Read more…]
Data shows patients surveyed had low decision regret1 after testing with DecisionDx®-UM, regardless of whether their uveal melanoma tumor was at high or low risk of metastasis FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced findings from a study that evaluated uveal … [Read more…]
AUSTIN, Texas–(BUSINESS WIRE)–Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors. Mr. Becker brings to Astrotech’s Board extensive leadership, with a focus on strategic market growth and expansion, and business process improvements and scaling, along with public speaking and corporate management skills. He will serve on each … [Read more…]
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry … [Read more…]
Completed last patient out milestone for PALISADE-1 Phase 3 clinical trial of PH94B in social anxiety disorder (SAD). Topline results for PALISADE-1 anticipated mid-2022. PALISADE-2 on track for topline readout in late 2022. Received FDA consensus that data from nonclinical and clinical studies of PH94B completed to date provide no signal of abuse potential. SOUTH … [Read more…]
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), anticipates releasing topline data from Part A of its ongoing Phase 2 study of ANEB-001 on July 5th. The results of the study, conducted in … [Read more…]
The employee health and wellness leader’s coaching graduates are now eligible to apply for the HWC Certifying Examination to become National Board Certified Health & Wellness Coach (NBC-HWC). NORWALK, Conn.–(BUSINESS WIRE)–#behavioralhealth—Zillion and its coaching team is proud to announce that the National Board for Health and Wellness Coaching (NBHWC) has approved Zillion’s Restore Coach Institute … [Read more…]
Historic Moment for California’s Cannabis Industry SACRAMENTO, Calif.–(BUSINESS WIRE)–#cannabis–The CA State Fair Cannabis Awards today announced the inaugural award-winning cultivars and cultivators from throughout California. More than 300 entries were evaluated for this year’s competition. A total of 60 trophies and medals were awarded, consisting of gold and silver medals by division and category, as … [Read more…]
HIV and LGBTQ+-focused health care services organization adds former U.S. surgeon general and industry leader to gain public health expertise and insight. PLANO, Texas–(BUSINESS WIRE)–Avita, the leading HIV-focused pharmacy services organization in the nation, today announced the appointment of two new members to its Board of Directors, effective July 1: Jerome Adams, MD, MPH, FASA, … [Read more…]
